Renaissance Technologies’s Scopus BioPharma Inc. Common Stock SCPS Stock Holding History

Renaissance Technologies’s Portfolio SCPS Stock Details SCPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-61,104	Closed	-$15K	–	4549
2022 Q3	$15K	Sell	61,104 -69,748	-53%	-$25.3K	﹤0.01%	3929
2022 Q2	$56K	Buy	130,852 +18,329	+16%	+$8.81K	﹤0.01%	3982
2022 Q1	$78K	Buy	112,523 +91,623	+438%	+$88.4K	﹤0.01%	3832
2021 Q4	$34K	Buy	+20,900	New	+$63.4K	﹤0.01%	3813

Other funds holding SCPS

MRCM

M&R Capital Management Summit, New Jersey $454M AUM 40.11% 1-Year Est. Return

Renaissance Technologies's SCPS Position: Q4 2022 in Review

Renaissance Technologies sold out of Scopus BioPharma Inc. Common Stock (SCPS) in Q4 2022, closing a stake of 61,104 shares — an estimated $15K sold.

Renaissance Technologies first reported a position in SCPS in Q4 2021 and held it in 4 quarters. The position peaked at $78K in Q1 2022. 1 fund tracked by Wall St. Rank holds SCPS as of Q4 2022.

Renaissance Technologies reported no remaining Scopus BioPharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Renaissance Technologies sold 61,104 Scopus BioPharma Inc. Common Stock shares in Q4 2022, an estimated $15K.
Renaissance Technologies first reported a position in Scopus BioPharma Inc. Common Stock in Q4 2021 and held it in 4 quarters.
Renaissance Technologies's Scopus BioPharma Inc. Common Stock position peaked at $78K in Q1 2022.
1 fund tracked by Wall St. Rank held Scopus BioPharma Inc. Common Stock as of Q4 2022.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.